FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3211081 · Received July 8, 2013

Report

Report Number
2124215-2013-10073
Event Type
Injury
Date Received
July 8, 2013
Date of Event
April 26, 2013
Report Date
April 26, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, RESISTANCE TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. VISUAL INSPECTION OF THE LEAD REVEALED A SEPARATION OF THE GORE COVERING FROM THE MEDICAL ADHESIVE (MA) AT THE PROXIMAL EDGE OF THE PROXIMAL SHOCKING COIL. ASSOCIATED WITH THIS WAS A SLIGHT STRETCHING OF THE PROXIMAL END OF THIS SHOCKING COIL. THE SEPARATION WAS A RESULT OF EXCESSIVE DRAG ON THE GORE AND THE SHOCKING COILS. UNDER NORMAL CIRCUMSTANCES, SEPARATION OF THE GORE COVERING WILL NOT IMPACT THE FUNCTIONALITY OF THE LEAD. MICROSCOPIC INSPECTIONS OF THE ELECTRODE TIP AND HELIX FOUND NO ANOMALIES WHICH WOULD LEAD TO DISLODGEMENT.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A DEVICE CHANGE OUT PROCEDURE THIS IMPLANTABLE DEFIBRILLATION LEAD HAD DISLODGED. THE LEAD WAS SUCCESSFULLY REPOSITIONED DURING THE PROCEDURE. APPROXIMATELY, A WEEK LATER THIS LEAD EXHIBITED LOSS OF CAPTURE AND WAS FOUND TO HAVE DISLODGED. AN INVASIVE PROCEDURE WAS PERFORMED. THE LEAD WAS EXPLANTED AND SUCCESSFULLY REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310938 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 73 YR Hospitalization| L| R N119| 5076| 4543| 4555| 0185| N161| MISMATCH| 5092